Breakthrough in Understanding Cancer’s Immune Evasion

Researchers from the Institute of Cancer Research in London, the Human Technopole in Milan, and Chalmers University of Technology in Sweden have discovered a pivotal event in how cancer cells manage to hide from the immune system. This event is known as immune evasion, where cancer cells avoid detection and continue to grow unchecked.

Immune Evasion Process

During immune evasion, bowel cancer cells disable the genes that allow the immune system to recognize them as a threat. Once this occurs, researchers found that the cancer’s ability to disguise itself remains relatively stable as it grows. This process makes it difficult for the immune system to identify and attack cancer cells.

These findings are significant as they may help doctors identify patients who are most likely to respond to immunotherapy, including experimental vaccines for bowel cancer that aim to train the immune system to target and destroy cancer cells.

Importance of the Discovery

Professor Trevor Graham, Director of the Centre for Evolution and Cancer, explained that some types of bowel cancer have the ability to outsmart the immune system from the outset. He noted that immunotherapies and bowel cancer vaccines hold great promise in treating the disease. Understanding how tumors evolve and change over time has become increasingly important with the development of personalized cancer treatment.

Graham mentioned that the relationship between bowel cancer and the immune system does not change significantly as the tumor grows. Therefore, targeting this relationship early on may increase the chances of treatment success.

Challenges and Potential Treatments

Bowel cancer is the fourth most common cancer in the UK, with approximately 44,100 new cases each year. Although about 15% of these cases respond well to immunotherapy, the majority remain resistant to this type of treatment.

Clinical trials are currently underway to test various types of bowel cancer vaccines, which aim to help the immune system recognize new or returning cancer cells after surgery or other treatments.

Role of Genetic Changes

The study found that genetic changes in cancer cells affect how DNA is read to produce RNA, which carries instructions for making proteins. These changes can reduce the number of proteins that alert the immune system to danger, making it harder for the immune system to recognize and destroy the tumor.

Researchers believe that combining immunotherapy with drugs that modify the genome could improve treatment outcomes. Such a combination might increase the number of proteins displayed by cancer cells, making it easier for the immune system to target them.

Conclusion

Understanding the early stages of bowel cancer can provide new insights into developing targeted and effective treatments. By tracking the initial stages of the disease, the research team has shed light on a mechanism that could lead to improved health outcomes for patients in the long term. This study is a powerful example of exploratory science contributing to a better understanding of cancer and the development of new therapeutic strategies.